Literature DB >> 25372225

Secular trends in invasive meningococcal disease, Massachusetts, 1988-2011: what happened to invasive disease?

A H Peruski1, P Kludt2, R S Patel3, A DeMaria2.   

Abstract

Invasive meningococcal disease (IMD) reported to the Massachusetts Department of Public Health from 1988 to 2011 was reviewed. The average annual incidence of IMD/100 000 decreased from 1·57 [95% confidence interval (CI) 1·42-1·73] for 1988-1991 to 0·22 (95% CI 0·17-0·29) for 2008-2011. The pattern of decreasing incidence over time differed by age group. There was a decrease in IMD/100 000 in the 0-4 years age group after 1991 from 10·92 (95% CI 8·08-14·70) in 1991 to 5·76 (95% CI 3·78-8·72) in 1992. Incidence in the 0-4 years age group remained below 5/100 000 per year on average thereafter. A substantial reduction in incidence in all age groups was observed between 2000 and 2009, which began before the introduction of conjugate meningococcal vaccine in 2005. Marked reductions in incidence of IMD in Massachusetts, and elsewhere, deserve further investigation with respect to potential factors that go beyond the introduction and deployment of improved meningococcal vaccines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25372225      PMCID: PMC9151323          DOI: 10.1017/S0950268814000259

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  30 in total

1.  Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.

Authors:  M Diermayer; K Hedberg; F Hoesly; M Fischer; B Perkins; M Reeves; D Fleming
Journal:  JAMA       Date:  1999-04-28       Impact factor: 56.272

2.  National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-08-26       Impact factor: 17.586

Review 3.  Epidemiological profile of meningococcal disease in the United States.

Authors:  Lee H Harrison
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

4.  National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-31       Impact factor: 17.586

5.  Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.

Authors:  Amanda C Cohn; Jessica R MacNeil; Lee H Harrison; Cynthia Hatcher; Jordan Theodore; Mark Schmidt; Tracy Pondo; Kathryn E Arnold; Joan Baumbach; Nancy Bennett; Allen S Craig; Monica Farley; Ken Gershman; Susan Petit; Ruth Lynfield; Arthur Reingold; William Schaffner; Kathleen A Shutt; Elizabeth R Zell; Leonard W Mayer; Thomas Clark; David Stephens; Nancy E Messonnier
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

6.  Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989-2010).

Authors:  S Ben-Shimol; R Dagan; Y Schonmann; N Givon-Lavi; N Keller; C Block; I Kassis; M Ephros; D Greenberg
Journal:  Infection       Date:  2013-03-10       Impact factor: 3.553

7.  Declining incidence of meningococcal disease in Denmark, confirmed by a capture-recapture analysis for 1994 and 2002.

Authors:  M F Howitz; S Samuelsson; K Mølbak
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

8.  National vaccination coverage among adolescents aged 13-17 years--United States, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-08-31       Impact factor: 17.586

9.  Serogroup C meningococcal outbreaks in the United States. An emerging threat.

Authors:  L A Jackson; A Schuchat; M W Reeves; J D Wenger
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

10.  Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland.

Authors:  M Catherine McEllistrem; John A Kolano; Margaret A Pass; Dominique A Caugant; Aaron B Mendelsohn; Antonio Guilherme Fonseca Pacheco; Kathleen A Shutt; Jafar Razeq; Lee H Harrison
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

View more
  2 in total

1.  Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013.

Authors:  Michael Bröker; Stéphane Emonet; Cecilia Fazio; Susanne Jacobsson; Maria Koliou; Markku Kuusi; David Pace; Metka Paragi; Alexander Pysik; Maria João Simões; Anna Skoczynska; Paola Stefanelli; Maija Toropainen; Muhamed-Kheir Taha; Georgina Tzanakaki
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.

Authors:  Sandra Guedes; Isabelle Bertrand-Gerentes; Keith Evans; Florence Coste; Philipp Oster
Journal:  BMC Public Health       Date:  2022-02-23       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.